# Topical 2-Deoxy-D-ribose Hydrogel Versus Minoxidil 5% Solution for Androgenetic Alopecia

> **NCT07502976** · NA · RECRUITING · sponsor: **Kasr El Aini Hospital** · enrollment: 60 (estimated)

## Conditions studied

- Androgenic Alopecia

## Interventions

- **DRUG:** Topical 2-Deoxy-D-ribose Hydrogel
- **DRUG:** Topical Minoxidil 5% Solution

## Key facts

- **NCT ID:** NCT07502976
- **Lead sponsor:** Kasr El Aini Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-01-01
- **Primary completion:** 2026-10
- **Final completion:** 2027-01
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-04-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07502976

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07502976, "Topical 2-Deoxy-D-ribose Hydrogel Versus Minoxidil 5% Solution for Androgenetic Alopecia". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07502976. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*